...
首页> 外文期刊>Agriculture and Natural Resources >Antimicrobial activity optimization of nisin, ascorbic acid and ethylenediamine tetraacetic acid disodium salt (EDTA) against Salmonella Enteritidis ATCC 13076 using response surface methodology
【24h】

Antimicrobial activity optimization of nisin, ascorbic acid and ethylenediamine tetraacetic acid disodium salt (EDTA) against Salmonella Enteritidis ATCC 13076 using response surface methodology

机译:响应面法优化乳链菌肽,抗坏血酸和乙二胺四乙酸二钠盐(EDTA)对肠炎沙门氏菌ATCC 13076的抗菌活性

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Nisin is a commercial bacteriocin produced by Lactococcus lactis subsp. lactis and widely used as a natural preservative in the food industry. However, while nisin alone cannot inhibit the growth of Gram-negative bacteria, it can in combination with a chelating agent or organic acid. This study combined nisin with some chelating agents, weak organic acids and their salts to inhibit Salmonella Enteritidis ATCC 13076. The combinations of nisin (2000?parts per million; ppm) and ascorbic acid (2000?ppm) or ethylenediamine tetraacetic acid disodium salt (EDTA; 7400?ppm) showed significant inhibitory effects on the target strain. Due to regulatory limits, the second part of the study reduced the concentrations of nisin, ascorbic acid and EDTA to 500?ppm, 2000?ppm and 250?ppm, respectively. The mixture of nisin, ascorbic acid and EDTA showed the highest inhibitory effect with a reduction number of 3.41 log colony forming units ( p ??0.05). To minimize the growth of S . Enteritidis ATCC 13076, central composite design and response surface methodology were applied to investigate the combined effect of nisin (0–500?ppm), ascorbic acid (0–2000?ppm), and EDTA (0–250?ppm) on the target strain growth. Among the three factors, nisin had a higher antimicrobial effect than ascorbic acid or EDTA, while an increase in nisin resulted in a decrease in S . Enteritidis ATCC 13076 growth. The optimum concentration was 500?ppm nisin with 1515?ppm ascorbic acid and 250?ppm EDTA. Under these conditions, the growth of S. Enteritidis ATCC 13076 predicted by the model was 24.99%.
机译:乳链菌肽是由乳酸乳球菌亚种产生的商业细菌素。乳酸,在食品工业中广泛用作天然防腐剂。然而,虽然单独的乳链菌肽不能抑制革兰氏阴性细菌的生长,但是它可以与螯合剂或有机酸结合使用。这项研究结合了乳链菌肽和某些螯合剂,弱有机酸及其盐类,以抑制肠炎沙门氏菌ATCC13076。乳链菌肽(2000?ppm / ppm)和抗坏血酸(2000?ppm)或乙二胺四乙酸二钠盐( EDTA; 7400ppm)对目标菌株表现出明显的抑制作用。由于法规的限制,研究的第二部分将乳链菌肽,抗坏血酸和EDTA的浓度分别降低至500?ppm,2000?ppm和250?ppm。乳链菌肽,抗坏血酸和EDTA的混合物显示出最高的抑制作用,减少了3.41log菌落形成单位(p <0.05)。最小化S的增长。应用肠炎沙门氏菌ATCC 13076,中心复合材料设计和响应面方法研究乳酸链球菌素(0–500?ppm),抗坏血酸(0–2000?ppm)和EDTA(0–250?ppm)对目标的综合作用应变增长。在这三个因素中,乳链菌肽的抗微生物作用比抗坏血酸或EDTA高,而乳链菌肽的增加导致S的降低。肠炎ATCC 13076增长。最佳浓度为500?ppm乳链菌素,1515?ppm抗坏血酸和250?ppm EDTA。在这些条件下,该模型预测的肠炎沙门氏菌ATCC 13076的增长率为24.99%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号